Thomas A. Fox

2.4k total citations · 1 hit paper
37 papers, 1.0k citations indexed

About

Thomas A. Fox is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Thomas A. Fox has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 11 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Thomas A. Fox's work include Anorectal Disease Treatments and Outcomes (6 papers), Colorectal and Anal Carcinomas (4 papers) and COVID-19 and healthcare impacts (4 papers). Thomas A. Fox is often cited by papers focused on Anorectal Disease Treatments and Outcomes (6 papers), Colorectal and Anal Carcinomas (4 papers) and COVID-19 and healthcare impacts (4 papers). Thomas A. Fox collaborates with scholars based in United Kingdom, United States and Canada. Thomas A. Fox's co-authors include Peter Haas, Gabriel P. Haas, M Balázs, Marie Christiane Vekemans, Stephen Booth, Fernando Martín‐Moro, Inna Y. Gong, Thomas Chatzikonstantinou, Bruno Fattizzo and Abi Vijenthira and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gastroenterology.

In The Last Decade

Thomas A. Fox

34 papers receiving 974 citations

Hit Papers

Outcomes of patients with hematologic malignancies and CO... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas A. Fox United Kingdom 15 510 451 308 235 105 37 1.0k
Valérie Martinez France 15 249 0.5× 237 0.5× 375 1.2× 93 0.4× 350 3.3× 38 1.0k
Young Sook Park South Korea 19 392 0.8× 229 0.5× 123 0.4× 116 0.5× 425 4.0× 83 1.1k
Jean-Paul Escande France 11 356 0.7× 726 1.6× 245 0.8× 59 0.3× 401 3.8× 17 1.1k
Mousa A. Al‐Abbadi United States 18 300 0.6× 289 0.6× 81 0.3× 70 0.3× 229 2.2× 87 990
Raavi Gupta United States 13 203 0.4× 92 0.2× 124 0.4× 120 0.5× 70 0.7× 55 593
L. Blum France 16 65 0.1× 408 0.9× 335 1.1× 191 0.8× 294 2.8× 53 1.1k
Jay Mehta United States 16 381 0.7× 113 0.3× 387 1.3× 49 0.2× 300 2.9× 66 864
Salvatrice Mancuso Italy 19 128 0.3× 260 0.6× 198 0.6× 46 0.2× 222 2.1× 71 1.1k
Reiko Kunisaki Japan 17 319 0.6× 137 0.3× 102 0.3× 132 0.6× 330 3.1× 73 1.1k
Guillemette Antoni France 17 294 0.6× 158 0.4× 249 0.8× 42 0.2× 301 2.9× 29 1.1k

Countries citing papers authored by Thomas A. Fox

Since Specialization
Citations

This map shows the geographic impact of Thomas A. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Fox more than expected).

Fields of papers citing papers by Thomas A. Fox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Fox. The network helps show where Thomas A. Fox may publish in the future.

Co-authorship network of co-authors of Thomas A. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Fox. A scholar is included among the top collaborators of Thomas A. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Fox. Thomas A. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fox, Thomas A. & Claire Booth. (2024). Improving access to gene therapy for rare diseases. Disease Models & Mechanisms. 17(6). 8 indexed citations
3.
Pinder, Christopher L., Thomas A. Fox, Amy A. Kirkwood, et al.. (2023). Humoral and cellular responses to SARS‐CoV‐2 in patients with B‐cell haematological malignancies improve with successive vaccination. British Journal of Haematology. 202(6). 1091–1103. 4 indexed citations
4.
Alrubayyi, Aljawharah, Emma Touizer, Ester Gea‐Mallorquí, et al.. (2023). Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1. Scientific Reports. 13(1). 18994–18994. 6 indexed citations
5.
Fox, Thomas A., Lina Petersone, Erin Waters, et al.. (2022). Therapeutic gene editing of T cells to correct CTLA-4 insufficiency. Science Translational Medicine. 14(668). eabn5811–eabn5811. 21 indexed citations
6.
Fox, Thomas A., et al.. (2022). Gene Edited T Cell Therapies for Inborn Errors of Immunity. SHILAP Revista de lepidopterología. 4. 899294–899294. 4 indexed citations
8.
Fox, Thomas A., Amy A. Kirkwood, James Day, et al.. (2020). Clinical outcomes and risk factors for severe COVID‐19 in patients with haematological disorders receiving chemo‐ or immunotherapy. British Journal of Haematology. 191(2). 194–206. 49 indexed citations
9.
Chowdary, Pratima, David A. Slatter, Richard Morris, et al.. (2020). Impaired platelet‐dependent thrombin generation associated with thrombocytopenia is improved by prothrombin complex concentrates in vitro. Research and Practice in Thrombosis and Haemostasis. 4(2). 334–342. 5 indexed citations
10.
Vijenthira, Abi, Inna Y. Gong, Thomas A. Fox, et al.. (2020). Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 136(25). 2881–2892. 330 indexed citations breakdown →
11.
Fox, Thomas A., Ben Carpenter, Asim Khwaja, et al.. (2019). Utility of FDG-PET/CT in Lymphoblastic Lymphoma. Blood. 134(Supplement_1). 2890–2890. 1 indexed citations
12.
Fox, Thomas A., Michael P. Lunn, Ashutosh Wechalekar, et al.. (2018). [18F]Florbetaben PET-CT confirms AL amyloidosis in a patient with Waldenström’s Macroglobulinemia. Haematologica. 103(7). e322–e324. 3 indexed citations
13.
Khaled, Yazan S., Deep J. Malde, Jessica Packer, et al.. (2014). Laparoscopic versus open cystgastrostomy for pancreatic pseudocysts: a case‐matched comparative study. Journal of Hepato-Biliary-Pancreatic Sciences. 21(11). 818–823. 24 indexed citations
14.
Malde, Deep J., et al.. (2012). OC-062 A comparative study of laparoscopic vs open cystgastrostomy for pancreatic pseudocysts. Gut. 61(Suppl 2). A27.1–A27.
15.
Strowitzkí, Martin, Thomas A. Fox, & Gerhard F. Hamann. (2001). Transcranial Color‐Coded Sonography of a Vein of Galen Arteriovenous Malformation in an Adult. Journal of Neuroimaging. 11(2). 205–208. 4 indexed citations
16.
Haas, Peter, et al.. (1992). Results of abdominoperineal resections for failures after combination chemotherapy and radiation therapy for anal canal cancers. Diseases of the Colon & Rectum. 35(6). 574–578. 37 indexed citations
17.
Haas, Peter & Thomas A. Fox. (1990). The fate of the forgotten rectal pouch after Hartmann's procedure without reconstruction. The American Journal of Surgery. 159(1). 106–111. 14 indexed citations
18.
Haas, Peter, et al.. (1989). Malignant transformation of anorectal giant condyloma acuminatum (Buschke-Loewenstein tumor). Diseases of the Colon & Rectum. 32(6). 481–487. 80 indexed citations
19.
Haas, Peter, et al.. (1983). The prevalence of hemorrhoids. Diseases of the Colon & Rectum. 26(7). 435–439. 89 indexed citations
20.
Haas, Peter, et al.. (1982). Injection of a local anesthetic solution into hemorrhoidal bundles following rubber band ligation. Diseases of the Colon & Rectum. 25(1). 62–63. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026